Inve US ▾

Incyte (INCY) earnings

INCYTE CORP· Health Care

Results to
Mar 2026
Latest analysed call
Jun 2026 (Q2 FY26)
Balance sheet to
Dec 2025
Build an Inve Case for INCY

Company research is public. Sign in to keep your own companies, notes and cases.

Incyte earnings: last reported Tue, 28 Jul 2026, for the quarter ended Jun 2026.

Reported

The figures, each with its period

Each figure keeps its basis and period; nothing is filled in.

MetricValueChangeBasisPeriodNote
Revenue1,273 $ million+20.9% YoYQuarterly, as filedQuarter to Mar 2026Revenue from operations as filed.
Operating margin23.7 %+4.2 pts YoYOperating profit / revenueQuarter to Mar 2026For the quarter; a change is in percentage points.
Net profit303 $ million+91.7% YoYQuarterly, as filedQuarter to Mar 2026Profit after tax as filed.

Source: Inve data from filed results (SEC filings) · to Mar 2026

Price

$113.27 +1.52% · +$1.7

Last close Oct 15, 2026 · US · USD

Performance +31.8% 1Y

$90$100$110$120$130Oct 25Nov 25Jan 26Feb 26Apr 26May 26Jul 26Aug 26Oct 26Mar 2026 (Q1 FY26) — 28 Apr 2026Jun 2026 (Q2 FY26) — 28 Jul 2026

1Y: $85.96 on 14 Oct 2025 → $113.27. High $129.93 (28 Jul 2026), low $85.96 (14 Oct 2025).

Previous close
$111.57
52-week range
$85.96 – $129.93
One year
+28.50%

Overview

Symbol
INCY
Exchange
US
Currency
USD

Your own record

Start an Inve Case for INCYTE CORP

Free account. Everything above stays public.

Write why you follow INCYTE CORP and the condition you want checked. Inve compares your numeric conditions with available results and management guidance; your own conditions remain yours to review.

Create your Inve Case What an account adds

Keep reading

Other US companies filed under I

All 118 companies under I

US companies A–Z · Earnings calls · US earnings-call directory · US sector analysis · What management promised, and delivered